lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

Comparative Safety of Haloperidol, Quetiapine and Risperidone in Elderly Patients with Stroke: Using Stroke Registry for External Adjustment

38 Pages Posted: 29 May 2020

See all articles by Chien-Chou Su

Chien-Chou Su

National Cheng Kung University - Institute of Clinical Pharmacy and Pharmaceutical Sciences; National Cheng Kung University - Health Outcome Research Center

Yea-Huei Kao Yang

National Cheng Kung University - Institute of Clinical Pharmacy and Pharmaceutical Sciences; National Cheng Kung University - Department of Pharmacy; National Cheng Kung University - Health Outcome Research Center

Edward Chia-Cheng Lai

National Cheng Kung University - School of Pharmacy

Cheng-Yang Hsieh

Tainan Sin Lau Hospital

Ching-Lan Cheng

National Cheng Kung University; National Cheng Kung University - Department of Pharmacy; National Cheng Kung University - Health Outcome Research Center

Chih-Hung Chen

Chang Gung University - Chang Gung Memorial Hospital

Huey-Juan Lin

Chi Mei Medical Center

Sheng-Feng Sung

Ditmanson Medical Foundation Chiayi Christian Hospital

Yu-Chen Wei

National Kaohsiung University of Science and Technology

More...

Abstract

Background: Antipsychotics remain the first choice of treatment for post-stroke psychosis, despite an increased risk of mortality reported in elderly patients. We aimed to compare the mortality risk among antipsychotics in elderly patients with stroke using the stroke registry for external adjustment.

Methods: We conducted a retrospective cohort study to identify patients aged above 65 years who were admitted for stroke in the National Health Insurance Database (NHID) from 2002 to 2014. The first date of antipsychotic use after the stroke hospitalization was defined as the index date. Covariates including diseases, medications and external information on smoking, BMI, stroke severity and disability, that were unavailable in the NHID were obtained from the linked Multicenter Stroke Registry (MSR) and used for propensity score calibration (PSC). The main outcome was one-year all-cause mortality

Findings: Stroke patients in the NHID prescribed with haloperidol, quetiapine and risperidone numbered 22 235, 28 702 and 8 663, respectively. In the PSC-adjusted analyses, haloperidol [adjusted hazard ratio (aHR) = 1.22; 95% CI 1.18–1.27] and risperidone (aHR = 1.31; 95% CI 1.24–1.38) users had a higher mortality risk than quetiapine users. Haloperidol and risperidone exhibited a dose-response relationship with mortality risk after controlling for confounders. When the dosage was higher than 0.5 defined daily dose (DDD), haloperidol and risperidone users had a significant mortality risk as compared with those taking a lower dose. The sensitivity analyses showed similar patterns.

Interpretation: In post-stroke elderly patients, quetiapine would be favored over risperidone and haloperidol at doses higher than 0.5 DDD. When haloperidol or risperidone is indicated, starting with a lower dose is suggested to avoid excess risk.

Funding Statement: This research was supported in part by the Ministry of Science and Technology, Taiwan [grant number MOST 107-2320-B-006-035].

Declaration of Interests: The authors declare they have no conflict of interest with respect to this research study and paper.

Ethics Approval Statement: The research protocol was approved by the Institutional Review Board of National Cheng Kung University Hospital (IRB No. A-EX-106-016).

Keywords: Stroke, antipsychotics, mortality risk, unmeasured confounders, propensity score calibration

Suggested Citation

Su, Chien-Chou and Kao Yang, Yea-Huei and Lai, Edward Chia-Cheng and Hsieh, Cheng-Yang and Cheng, Ching-Lan and Chen, Chih-Hung and Lin, Huey-Juan and Sung, Sheng-Feng and Wei, Yu-Chen, Comparative Safety of Haloperidol, Quetiapine and Risperidone in Elderly Patients with Stroke: Using Stroke Registry for External Adjustment (3/23/2020). Available at SSRN: https://ssrn.com/abstract=3562485 or http://dx.doi.org/10.2139/ssrn.3562485

Chien-Chou Su

National Cheng Kung University - Institute of Clinical Pharmacy and Pharmaceutical Sciences

Tainan
Taiwan

National Cheng Kung University - Health Outcome Research Center

Taiwan

Yea-Huei Kao Yang (Contact Author)

National Cheng Kung University - Institute of Clinical Pharmacy and Pharmaceutical Sciences ( email )

Tainan
Taiwan

National Cheng Kung University - Department of Pharmacy ( email )

Taiwan

National Cheng Kung University - Health Outcome Research Center ( email )

Taiwan

Edward Chia-Cheng Lai

National Cheng Kung University - School of Pharmacy

Tainan
Taiwan

Cheng-Yang Hsieh

Tainan Sin Lau Hospital

Tainan
Taiwan

Ching-Lan Cheng

National Cheng Kung University ( email )

No.1, University Road
Tainan
Taiwan

National Cheng Kung University - Department of Pharmacy ( email )

Taiwan

National Cheng Kung University - Health Outcome Research Center ( email )

Taiwan

Chih-Hung Chen

Chang Gung University - Chang Gung Memorial Hospital ( email )

No.199, Tunghwa Rd
Taipei
Taiwan

Huey-Juan Lin

Chi Mei Medical Center

Tainan
Taiwan

Sheng-Feng Sung

Ditmanson Medical Foundation Chiayi Christian Hospital

Chiayi
Taiwan

Yu-Chen Wei

National Kaohsiung University of Science and Technology ( email )

No. 1, University Road
Yanchao District
Kaohsiung City, Taiwan 824
Taiwan

Click here to go to TheLancet.com

Paper statistics

Abstract Views
180
Downloads
26
PlumX Metrics